We evaluated the progression of heterotopic ossification (HO) in 17 spinal cord injury patients by comparing radiographs, quantitative radionuclide bone scans, and serum alkaline phosphatase levels. Evidence of maturation of HO appeared earlier (3 months to 6 years post injury) in radiographs, whereas, during the same time frame, radioactive nuclide assessment showed continued progression of HO in 10 out of the 17 patients. The evolution of HO appeared to take place over a period ranging between 3 and 80 months. We believe that stabilization of HO may be reasonably defined in terms of uptake ratios of 2.0 or less in patients with initial uptake ratios over 3.0 but below 5.0, and of ratios of 3.0 or less when the initial values are over 5. 0.
Introduction
The radionuclide bone scan following neurological injury is capable of detecting heterotopic ossification (HO) earlier than by radiographic means. Initially, the local features of HO may simulate those of deep venous thrombosis or cellulitis. As it is too early to visualize HO by radiographs at this time, the bone scan is, up to the present time, the only way to establish the diag nosis. It also permits temporal definition of the interval during which HO stabilizes or matures. This is of particular importance in determining the correct time for operative resection of the mass, because of the poten tial for postoperative recurrence. [1] [2] [3] Clinically it is of value to be able to assess the progression, maturation, stabilization, and duration of HO in order to deal with this disturbing complication of spinal cord injury. There are few references in the literature4,5 to follow up studies of the progression of HO. The evaluation of bone scan findings has heretofore been of a qualitative rather than of a quantitative nature. The purpose of this report is to provide a quantitative evaluation of the progression of HO in a series of spinal cord patients.
Material and methods
Seventeen traumatic myelopathy patients with newly developed HO, all males, were studied. They ranged in age from 28 to 68 (average 40.3) years. Thirteen were white and 4 black. The level of injury was cervical in 13 and thoracic in 4. The postinjury interval before there was recognition of HO was less than one month in 3 patients, 1-2 months in 6, 2-3 months in 4, 3-6 months in 2, and over 6 months in 2. All patients were treated with etidronate sodium (disodium I-hydroxyethane diphosphonate, EHDP), 20 mg per kg for 2 weeks, which was then decreased to 10 mg per kg for 10 weeks. If a high radionuclide uptake persisted, EHDP was maintained until the uptake was con sidered stabilized.
An attempt was made to grade the HO according to the following scale: grade 1, minimal involvement with ossification of less than 3 cm in maximum dimension; grade 2, partial joint capsule involvement, with more than 3 cm but less than 7 cm of ossification; grade 3, involvement of most of the joint capsule with partial ankylosis of the joint, and more than 7 cm but less than 15 cm of ossification; grade 4, complete involvement of the joint capsule, with total ankylosis and more than 15 cm of ossifi cation.
Routine hip radiographs were taken on admission. As soon as the radiographs demonstrated HO by periodical check every 3 weeks, a computerized bone scan was carried out, except in one patient (case # 15) who never showed HO radiographically. In this latter patient, a bone scan was per formed because of the presence of a mass with swelling, which raised the suspicion of impending HO. Interestingly, bone scans in some individuals disclosed the presence of HO at additional sites, eg the knees, thighs, and shoulders; these findings were sub sequently confirmed radiographically. Approximately 3 hours following the iv administration of 20 millicuries of 99m-tech netium methylene diphosphonate (Tc99m MOP), a total-body PHO/CON bone scan was obtained from the head to below the knees. When HO was identified, additional views were obtained with an LFOV gamma camera with a parallel-hole collimator. The camera scintigraphic digital 5-minute images, either in an anterior or in a post erior projection, were stored on a computer (MOS A2 with a 80-megabyte disk) in a 128 x 128 matrix. The patients were placed in a supine or prone position with the camera oriented perpendicular to the hori zontal plane of the scanning table. Extreme care was taken to avoid obliquity. In the digital images, the regions of interest (ROIs) were placed visually over the area of HO. An identical ROI was placed over the uninvolved contralateral joint. When both joints were involved, a third area without bony (background) activity was used. The background regions chosen were either in the paralumbar compartment below the kidneys or in the parafemoral region in the thigh. At these sites, background activity is derived entirely from nonosseous tissue (mainly muscle and skin), and we assumed there would be no significant changes in muscle mass or skin thickness during the course of the interval studies. To ensure reproducibility, digital images were recorded over the same period (160-200 min) after Tc99m-MOP injection, and in the same projection. Total counts were obtained either over the ROI or the background region. Serial quantitative deter minations were made of the ratios of counts over affected joints and to those of control regions. Preliminary studies showed these ratios to be highly reproducible, with the mean coefficient of variation (CV) in 4 consecutive measurements in each of 2 patients, repositioned when each 5-minute image was taken, being 7.8% and 8.2% respectively.
All radiograph and bone scan results were evaluated by the same individual. Follow up radiographs were undertaken at one-month intervals and bone scans were repeated every 6 months unless rapid changes seemed to be taking place, in which case the intervals were shortened. Patients who were discharged before the bone scan results showed decreased uptake or who had evid ence of hepatobiliary disease were excluded from the study.
Stabilization of HO was defined as a combination of the following: (1) distinct ness of the outline of the HO in radio graphs; (2) maximum increase in the radio graphic density of the HO; (3) lack of further extension of HO radiographically; and (4) a steady decrease, on more than 2 successive determinations, of radionuclide uptake, with ratios below 2.0 if it was initially over 3.0 but below 5.0, and below 3.0 if it was initially over 5.0. These ratios were selected empirically and arbitrarily on the basis of a preliminary overview of the values obtained. This being a small series, no attempt was made at a statistical com parison of different cutoff points. These ratios, therefore, should be applied only in conjunction with the presence of other criteria, as outlined above.
Serum alkaline phosphatase (AP) levels were measured at 1-to 2-week intervals by the Bessey-Lowry-Brock method, as auto mated by Morgenstern et al;6 normal values were considered to be between 30 and 115 mu per ml.
Results
HO was found in 30 sites in 17 patients, as is shown in Table I . The number of sites involved was one in 11, 2 in 6, 3 in 1, and 4 in 1. In 10 of the 17 patients, radiographs Table II . Of these 10 patients, 4 showed bone scan findings delayed up to 3 months, 3 from 3 to 6 months, and 3 more than 12 months. These observations indicate that the progression of HO occurred over a period that lasted up to 3 months in 5 patients, from 3 to 6 months in 4, from 6 to 12 months in 3, and over 12 months in 5 (Table III) . Quantitative maxi mum radionuclide uptake ratios varied as is shown in Table III 
Discussion
Statistical analysis of HO with regard to incidence, location, level of injury, com pleteness of paralysis, etc are published elsewhere.1-4 This study focuses on the progression of HO as determined by corre lating radiographic and quantitative radio nuclide bone scan findings and AP eleva tion. All patients were administered EHDP after HO was discovered. There are reports in the literature2 of continued progression of HO even with EHDP treatment in a small number of patients. This matter will be the subject of a later report.
In the majority (10 patients out of 17) radiographic evidence of HO maturation preceded that seen in bone scans, which remained positive with increased uptake for varying periods of time. In only 3 of 17 did bone scan results show stabilization earlier than in radiographs. Tanaka et al5 have emphasized that maturation of HO must be determined on the basis of bone scan findings in order to arrive at a proper decision regarding the timing of surgical intervention for HO.
Since the progression of HO may differ from one patient to the next, maturation of HO even as seen in bone scans may have considerable variations, ranging from 3 months to 6 years (average 18.9 months) in our patients. This may be the reason why the HO grade did not correlate with the duration of evolution of HO. In one of our patients uptake suddenly increased after it had decreased in successive determinations. Such an experience has also been recorded by others, 5.7 who concluded that, in order to judge HO to be mature, a continuous decrease of the uptake ratio should be followed by a 'steady-state' over a period covering at least 2 or 3 consecutive monthly examinations. These authors concluded, moreover, that if there is a steady decrease in uptake over several months, then sur gery, even before a steady-state is reached, will result in a small risk of recurrence. Stover2 observed that the precipitating fac tors that induce bone growth or new foci of HO included severe systematic illness, hep atic failure, surgery in the HO area, infec tion, trochanteric bursitis, and pressure ulcers.
There are no published computerized bone scan criteria for the diagnosis of stabilized HO. We believe, on the basis of this study, that scan uptake ratios of 2. 0 (for cases with an initial uptake ratio of over 3. 0, but below 5. 0) and 3. 0 (for cases with an initial uptake ratio of over 5.0) are reason able criteria for maturation. These criteria, however, may be difficult to apply when there is grade 1 or 2 HO.
One possible critique of this study is that EHDP treatment may affect the natural history of HO. As Finerman et al8 and Stover et al9 have stated, EHDP is effective in actually preventing HO formation. It has a high affinity for the calcium ion of hydroxapatite, inhibiting its crystalline growth. All patients in our study, however, were given EHDP after HO was found. The manner in which EHDP affects the uptake ratios is not known.
We do not believe that serum AP levels are reliable indicators of HO. As we have reported recently, 10 increased AP alone is not diagnostic, but an increase of both AP and inorganic phosphorus shows a statisti cally significant correlation. Although no statistically significant relationship to AP levels could be adduced in this study, there was a tendency towards increased values among HO cases, possibly because most of the patients observed suffered HO of grade 2 or higher severity. It has been suggested by others that the more marked the HO, the more persistent the rise in AP levels. 1 As all of our patients were receiving EHDP, in organic phosphorus levels were consistently elevated.
Conclusions
A steady decline in radionuclide uptake was observed to extend anywhere from 3 months to 6 years beyond the time of radiographic maturation in 10 of 17 patients with HO. Evidence of maturation as seen in bone scans occurred earlier than was seen in radiographs in 3 patients, and maturation appeared to be simultaneous in 4. The evolution of HO was seen to take place over a period ranging between 3 and 80 months, for reasons that are not clear. Quantitative determinations of uptake ratios varied from a minimum of 1.10 to a maximum of 7. 22, with higher grades of HO corresponding to higher levels of uptake. We feel that, for grades of HO above 2, stabilization may be defined in terms of uptake ratios or 2. 0 or References less, provided that the initial uptake ratios are greater than 3. 0. In cases in which initial uptake ratios are over 5.0, stabilization is indicated by uptake ratios of 3.0 or less. For grade 1 and grade 2 HO, however, these criteria may not apply. Finally, elevation of serum AP levels seems to occur only in association with the formation of HO above grade 2.
